once weekly glp 1 Medscape | semaglutide injections reduced alcohol consumption in patients with alcohol use disorder and comorbid obesity. Results of the Is once-weekly semaglutide (Glucagon-like peptide-1

[DOI] [PMC free article] [PubMed] [Google Scholar] 29.McGowan BM, Bruun JM, Capehorn M, et al

Industry experts say the next phase of growth will depend on the availability of affordable generic alternatives, wider adoption beyond major cities, and increasing awareness among patients seeking obesity and metabolic health treatments

Watch for signs that the medication is reinforcing disordered eating behaviors including feeling relief rather than concern about not eating, developing rigid rules around certain foods, or noticing that family members are expressing concern about your eating patterns or weight loss

You deserve clear information and a supportive guide

Both are controlled substances and have the potential for abuse